Dekstropropoksifen
 | |
 | |
| Klinički podaci | |
|---|---|
| Prodajno ime | Algafan, Antalvic, Darvon, Deprancol |
| Drugs.com | Monografija |
| Način primene | Oralno |
| Farmakokinetičkipodaci | |
| Poluvreme eliminacije | 6-12 h |
| Izlučivanje | Renalno |
| Identifikatori | |
| CAS broj | 469-62-5 |
| ATC kod | N02AC04(WHO),N02AC74 |
| PubChem | CID10100 |
| DrugBank | DB00647 |
| ChemSpider | 9696 |
| KEGG | C07406 |
| ChEBI | CHEBI:8497 |
| ChEMBL | CHEMBL1213351 |
| Hemijski podaci | |
| Formula | C22H29NO2 |
| Molarna masa | 339,471 |
| |
| |
| Fizički podaci | |
| Tačka topljenja | 755 °C (1.391 °F) |
Dekstropropoksifenjeorgansko jedinjenje,koje sadrži 22atomaugljenikai imamolekulsku masuod 339,471Da.[1][2][3]
Osobine
[уреди|уреди извор]| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 3 |
| Broj donora vodonika | 0 |
| Broj rotacionih veza | 9 |
| Particioni koeficijent[4](ALogP) | 4,7 |
| Rastvorljivost[5](logS,log(mol/L)) | -5,8 |
| Polarna površina[6](PSA,Å2) | 29,5 |
Reference
[уреди|уреди извор]- ^Coda BA, Rudy AC, Archer SM, Wermeling DP: Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers. Anesth Analg. 2003 Jul;97(1):117-23, table of contents.PMID12818953
- ^Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011).„DrugBank 3.0: a comprehensive resource for omics research on drugs”.Nucleic Acids Res.39(Database issue): D1035—41.PMC3013709
.PMID21059682.doi:10.1093/nar/gkq1126.
- ^David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008).„DrugBank: a knowledgebase for drugs, drug actions and drug targets”.Nucleic acids research.36(Database issue): D901—6.PMC2238889 .PMID18048412.doi:10.1093/nar/gkm958.
- ^Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998).„Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”.J. Phys. Chem. A.102:3762—3772.doi:10.1021/jp980230o.
- ^Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001).„Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”.Chem Inf. Comput. Sci.41:1488—1493.PMID11749573.doi:10.1021/ci000392t.
- ^Ertl P.; Rohde B.; Selzer P. (2000).„Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”.J. Med. Chem.43:3714—3717.PMID11020286.doi:10.1021/jm000942e.
Literatura
[уреди|уреди извор]- Hardman JG, Limbird LE, Gilman AG (2001).Goodman & Gilman's The Pharmacological Basis of Therapeutics(10. изд.). New York: McGraw-Hill.ISBN0071354697.doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007).Foye's Principles of Medicinal Chemistry(6. изд.). Baltimore: Lippincott Willams & Wilkins.ISBN0781768799.
Spoljašnje veze
[уреди|уреди извор]
 | Molimo Vas, obratite pažnju navažno upozorenje u vezi sa temama izoblasti medicine (zdravlja). |
